BAJAJ BROKING

Notification close image
No new Notification messages
card image
Ellenbarrie Industrial Gases IPO is Open!
Apply for the Ellenbarrie Industrial Gases IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Accretion Pharmaceuticals Ltd

Pharmaceuticals

Offer Period :

14th to 16th May 2025

Accretion Pharmaceuticals Ltd IPO Details

IPO Date 14th to 16th May 2025 Minimum Investment ₹121200 / 1 Lots
Listing Date 2025-05-21 Maximum Investment ₹121200 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹29.75 Crores
Price ₹101 to ₹101 per share Fresh Issue ₹29.75 Crores
Lot Size 1 Lots (1200 Shares) Offer For Sale ₹ [-]
Listing At NSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 8170000 Shares
Issue Type Book Building - SME Shareholding Post Issue 11116000 Shares
IPO Date 14th to 16th May 2025
Listing Date 2025-05-21
Face Value ₹10 per share
Price ₹101 to ₹101 per share
Lot Size 1 Lots (1200 Shares)
Listing At NSE-SME
Total Issue Size ₹29.75 Crores
Employee Discount ₹0 per share
Issue Type Book Building - SME
Minimum Investment ₹121200 / 1 Lots
Maximum Investment ₹121200 / 1 Lots
Fresh Issue ₹29.75 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 8170000 Shares
Shareholding Post Issue 11116000 Shares

About Accretion Pharmaceuticals Ltd IPO

Accretion Pharmaceuticals Limited, incorporated in 2012, is a growing pharmaceutical company primarily engaged in the manufacturing and marketing of a wide range of healthcare products. Its offerings include tablets, capsules, oral liquids, and various external preparations such as ointments, creams, gels, lotions, medicated shampoos, mouthwash, and dusting powders, as well as oral powders like sachets and dry syrups. The company caters to both direct sales and contract manufacturing clients, operating majorly on a principal-to-principal business model. With ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018 certifications, Accretion Pharmaceuticals demonstrates a strong commitment to quality and regulatory compliance.
 

The company’s state-of-the-art manufacturing unit is situated in Sanand, Ahmedabad, Gujarat. Accretion Pharmaceuticals has established a robust presence in the domestic market while also extending its footprint globally, serving clients in over 20 countries across Africa, Southeast Asia, and the Middle East. Backed by an experienced board and a skilled management team, the company continues to focus on innovation, strategic partnerships, and regulatory excellence, positioning itself as a reliable player in the pharmaceutical manufacturing space.

Founding Head: 2023

Managing Director: Vivek Ashok Kumar Patel

Accretion Pharmaceuticals Limited Timeline

Important dates for allocation and IPO listing.

14th May

IPO Opens

16th May

IPO Close

19th May

Allotment Date

20th May

Initiation of Refund

20th May

Credit of Shares to Demat Account

21st May

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 100 73.14
Public Group 0 26.86

Accretion Pharmaceuticals Ltd IPO Reservation

QIB Shares Offered 352800(11.98%)
NII (HNI) Shares Offered 1222800(41.51%)
Retail Shares Offered 1222800(41.51%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 2946000
Total Shares With Anchor Investor 2946000

Accretion Pharmaceuticals Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1200 ₹121200
Retail (Max) 1 1200 ₹121200
S HNI (Min) 2 2400 ₹242400
S HNI (Max) 8 9600 ₹969600
B HNI (MIN) 9 10800 ₹1090800

Accretion Pharmaceuticals Ltd IPO Anchor Investor Details

Bid Date -
Shares Offered 0
Anchor Portion Size 0

Accretion Pharmaceuticals Ltd IPO Registrar

KFin Techologies Ltd
Phone Number +91-40-6716 2222/
Email Id apl.ipo@kfintech.com
Our Website www.kfintech.com

Accretion Pharmaceuticals Ltd IPO Lead Manager

1. Jawa Capital Services Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Accretion Pharmaceuticals Ltd Financial Information

Period Ended March 31, 2024 March 31, March 31,
Net Worth ₹5.49
Reserves and Surplus ₹1.49
Total Borrowing ₹13.48

Accretion Pharmaceuticals Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 352800 1719600 4.8742
Non Institutional Investors (NIIs) 1222800 5391600 4.4092
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 0 0 0
Retail Individual Investors (RIIs) 1222800 12895200 10.5456
Total 2734800 20006400 7.3155

Strength of Accretion Pharmaceuticals Ltd

1. Experienced Promoters and Management Team.

2. Consistently supplying quality products to our valued customers in time.

3. Continually improving the quality standards by implementing process control and prevention techniques.

4. Long-standing relationship with clients and suppliers.

5. Quality standards.

6. Legacy Business Process & Management.

7. Strong and experienced R&D team.

Industry Outlook of Accretion Pharmaceuticals IPO

  • India holds a significant position in the global pharmaceuticals sector.

  • Key segments include: generic medicines, OTC drugs, bulk drugs, vaccines, biosimilars, biologics, and contract research & manufacturing.

  • India is a global leader in vaccine production, particularly for DPT, BCG, and Measles vaccines.

  • The country is the world’s largest supplier of generic medicines, contributing 20% of global volume.

  • It also leads globally in vaccine manufacturing.

  • India hosts the highest number of US-FDA approved pharmaceutical plants outside the US.

  • The nation is home to over 3,000 pharmaceutical companies and has more than 10,500 manufacturing units.

  • It benefits from a vast pool of highly skilled professionals.

  • The Indian pharmaceutical industry is currently valued at $50 billion.

  • It is projected to grow to $65 billion by 2024 and $130 billion by 2030.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Accretion Pharmaceuticals IPO.

Risks Involved

1. A significant portion of its revenue is derived from exports, and any decline in export profitability may adversely impact its overall financial performance.

2. The Company operates in pharmaceutical sector, which is extensively regulated, any failures on the company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.

3. Its manufacturing units are subject to periodic inspections and audits by regulatory authorities and clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.

4. The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.

5. The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.

6. The company generate a significant percentage of its revenue from few clients. The loss of any one or more of the company major clients would have a material adverse effect on its business operations and profitability.

7. Its inability to accurately forecast demand for the company products or manage its inventory or working capital requirements may have an adverse effect on the company business, results of operations and financial condition.

8. There was a Criminal litigation against its promoters cum directors and the company is not sure the same shall not be refiled by the concerned authority. In the event it is refiled, the interest of the promoters may divert from the business of the Company, which may adversely affect the business of the Company.

9. Its business operations are working capital intensive, and any inability to meet the company working capital requirements may adversely impact its financial condition and growth prospects.

10. The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.

Why should you invest in

-

Accretion Pharmaceuticals Ltd Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Accretion Pharmaceuticals Limited IPO Contact Details

Accretion Pharmaceuticals Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-05-21 94000 ACCPL
INE0T8T01010
₹101 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹101 ₹101
Open ₹0 ₹79
Low ₹0 ₹75.05
High ₹0 ₹82.95
Low ₹0 ₹75.05

Frequently Asked Questions

What is Accretion Pharmaceuticals Ltd IPO?

Answer Field

Accretion Pharmaceuticals Ltd IPO is a SME IPO of 29,46,000 equity shares of a face value of ₹10 aggregating up to ₹29.75 Crores. The issue is priced at ₹101 to ₹101 per share. The minimum order quantity is 1200 Shares. The IPO opens on May 14, 2025, and closes on May 16, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Accretion Pharmaceuticals Ltd IPO will open?

Answer Field

The Accretion Pharmaceuticals Ltd IPO opens on May 14, 2025 and closes on May 16, 2025.

What is the lot size of Accretion Pharmaceuticals Ltd?

Answer Field

Accretion Pharmaceuticals Ltd lot size is 1200 shares, and the minimum amount required is ₹1,21,200.

How to apply for Accretion Pharmaceuticals Ltd IPO?

Answer Field

You can apply in Accretion Pharmaceuticals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Accretion Pharmaceuticals Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Accretion Pharmaceuticals Ltd IPO will be done on May 19, 2025, and the allotted shares will be credited to your demat account by May 20, 2025.

When is Accretion Pharmaceuticals Ltd IPO listing date?

Answer Field

The Accretion Pharmaceuticals Ltd listing date is May 21, 2025.

Who is the registrar of Accretion Pharmaceuticals Ltd IPO?

Answer Field

The registrar of Accretion Pharmaceuticals Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Jawa Capital Services Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Accretion Pharmaceuticals Ltd IPO?

Answer Field

The fresh issue size is ₹29.75 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Accretion Pharmaceuticals Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1200 shares and ₹1,21,200 amount.

How can I approve the UPI mandate request for Accretion Pharmaceuticals Ltd IPO?

Answer Field

To apply for Accretion Pharmaceuticals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Accretion Pharmaceuticals Ltd?

Answer Field

The price of each Accretion Pharmaceuticals Ltd share will be ranging in between ₹101 to ₹101 per share.

What is the cut-off time for the UPI mandate for Accretion Pharmaceuticals Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, May 16, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • MAYASHEEL VENTURES LIMITEDSME IPO

  • Bidding Dates

    20th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹44.0 - 47.0

  • IPO Size

    ₹27,28,00,000

  • Apply Now
  • GLOBE CIVIL PROJECTS LIMITEDMainboard IPO

  • Bidding Dates

    24th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹67.0 - 71.0

  • IPO Size

    ₹1,19,00,00,000

  • Apply Now
  • ABRAM FOOD LIMITEDSME IPO

  • Bidding Dates

    24th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹98.0 - 98.0

  • IPO Size

    ₹13,29,00,000

  • Apply Now
  • ICON FACILITATORS LIMITEDSME IPO

  • Bidding Dates

    24th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹85.0 - 91.0

  • IPO Size

    ₹18,15,00,000

  • Apply Now
  • KALPATARU LIMITEDMainboard IPO

  • Bidding Dates

    24th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹387.0 - 414.0

  • IPO Size

    ₹15,90,00,00,000

  • Apply Now
  • SUNTECH INFRA SOLUTIONS LIMITEDSME IPO Early Access

  • Bidding Dates

    25th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹81.0 - 86.0

  • IPO Size

    ₹42,16,00,000

  • Apply Now
  • SAMBHV STEEL TUBES LIMITEDMainboard IPO Early Access

  • Bidding Dates

    25th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹77.0 - 82.0

  • IPO Size

    ₹5,40,00,00,000

  • Apply Now
  • HDB FINANCIAL SERVICES LIMITEDMainboard IPO Early Access

  • Bidding Dates

    25th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹700.0 - 740.0

  • IPO Size

    ₹1,25,00,00,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • OSWAL PUMPS LIMITEDMainboard IPO

  • Bidding Dates

    13th Jun 2025 - 6th Jun 2025

  • Price Range

    ₹584.0 - 614.0

  • IPO Size

    ₹13,87,34,00,000

  • Invest Now
  • 3B FILMS LIMITEDSME IPO

  • Bidding Dates

    30th May 2025 - 6th Jun 2025

  • Price Range

    ₹50.0 - 50.0

  • IPO Size

    ₹33,75,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • OSWAL PUMPS LIMITEDMainboard IPO

  • Issue Price

    614.00

  • Listing Day Close

    624.90

  • Listing Day (Gain/Loss)

    1.79

  • SACHEEROME LIMITEDSME IPO

  • Issue Price

    102.00

  • Listing Day Close

    160.55

  • Listing Day (Gain/Loss)

    57.84

  • 3B FILMS LIMITEDSME IPO

  • Issue Price

    50.00

  • Listing Day Close

    46.08

  • Listing Day (Gain/Loss)

    -8.00

  • SCODA TUBES LIMITEDMainboard IPO

  • Issue Price

    140.00

  • Listing Day Close

    146.95

  • Listing Day (Gain/Loss)

    5.00

  • ASTONEA LABS LIMITEDSME IPO

  • Issue Price

    135.00

  • Listing Day Close

    135.65

  • Listing Day (Gain/Loss)

    0.74

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text